opportunity

Synopsis : The U.S. Food and Drug Administration, the National Institutes of Health, 10 pharmaceutical companies and five non-profit organizations have partnered…

KEYPOINTS FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine for Emergency Use in Children 5 through 11 Years of Age. Effectiveness: Immune responses of children…

  The Department of Pharmaceuticals (DoP) has come out with a draft policy to catalyse research and development (R&D) and innovation in…

Introduction The Medical Device industry is highly capital intensive with a long gestation period and requires development and induction of new technologies.…

Keypoints Pharmaceutical company Pfizer and biotechnology company BioNTech have requested to have their coronavirus vaccine licensed for children ages 5 to 11…